Family Medicine & Primary Care Review

Full text

3/2026 vol. 28
Review paper

Beyond heartburn: a practical approach to gastroesophageal reflux disease in primary care

Anna Pietrzak 1
,
Patryk Dziurzyński 2

  1. Second Department of Gastroenterology, Centre of Postgraduate Medical Education (CMKP), Warsaw, Poland

  2. Department of Gastroenterology, Bielański Hospital, Warsaw, Poland

Family Medicine & Primary Care Review 2026; 28(3): 330–335

DOI: https://doi.org/10.5114/fmpcr.2026.164664
Data publikacji online: 2026/09/29
Article file
14 FM&PCR 3 26 - R - Pietrzak - 2124 - Beyond.pdf
  1. Drossman DA, Hasler WL. Rome IV – Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology 2016; 150(6): 1257–1261.
  2. Aziz Q, Fass R, Gyawali CP, et al. Functional esophageal disorders. Gastroenterology 2016; 150(6): 1368–1379.
  3. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2014; 63(6): 871–880.
  4. Gyawali CP, Pandolfino JE, Savarino E, et al. Modern diagnosis of GERD: update from the Lyon Consensus. Gut 2023; 72(7): 1254–1263.
  5. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus 2.0. Gut 2024; 73(2): 361–371.
  6. Boeckxstaens G, El-Serag HB, Smout AJ, et al. Symptomatic reflux disease: the present, the past and the future. Gut 2014; 63(7): 1185–1193.
  7. Vakil N, Zanten SV, van, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease. Am J Gastroenterol 2006; 101(8): 1900–1920.
  8. Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2021; 19(4): 767–775.
  9. Gyawali CP, Carlson DA. Diagnosis and classification of GERD. Gut Liver 2022; 16(3): 305–320.
  10. Yadlapati R, Pandolfino JE. Personalized approach to the evaluation and management of GERD. Clin Gastroenterol Hepatol 2023; 21(5): 1087–1095.
  11. Suzuki H, Hibi T. Overlap syndrome of GERD and functional dyspepsia. J Gastroenterol Hepatol 2023; 38(2): 177–184.
  12. Siah KTH, Gong EJ, Yang YJ, et al. Overlap of gastroesophageal reflux disease and functional dyspepsia and yield of esophagogastroduodenoscopy in patients clinically fulfilling the Rome IV criteria for functional dyspepsia. J Neurogastroenterol Motil 2022; 28(4): 593–601.
  13. Kim SE, Park MI, Kim SH, et al. Overlap between gastroesophageal reflux disease and functional dyspepsia. J Neurogastroenterol Motil 2024; 30(3): 321–332.
  14. Gyawali CP. Extraesophageal manifestations of GERD. Gastroenterol Clin North Am 2014; 43(1): 39–54.
  15. Świdnicka-Siergiejko A, Marek T, Waśko-Czopnik D, et al. Diagnostic and therapeutic management in gastroesophageal reflux disease: consensus of the Polish Society of Gastroenterology. Pol Arch Intern Med 2022; 132(7–8): 16295.
  16. Gyawali CP, Carlson DA, Chen JW, et al. ACG Clinical Guidelines: Clinical Use of Esophageal Physiologic Testing. Am J Gastroenterol 2023; 118(9): 1512–1534.
  17. Savarino E, Gyawali CP, Yadlapati R, et al. Expert consensus document: Advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol 2023; 20(10): 671–684.
  18. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. Am J Gastroenterol 2022; 117(1): 27–56.
  19. Patel A, Yadlapati R. Management of functional heartburn. Gastroenterology 2020; 158(8): 2286–2293.
  20. Bansal A, Sharma P. Barrett’s esophagus and peptic strictures in GERD. Best Pract Res Clin Gastroenterol 2010; 24(6): 873–887.
  21. Fass R, Shapiro M, Dekel R, et al. Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005; 22(2): 79–94.
  22. Kahrilas PJ, Jonasson C, Denison H, et al. Regurgitation is less responsive to acid suppression than heartburn in GERD. Clin Gastroenterol Hepatol 2012; 10(6): 612–619.
  23. Waśko-Czopnik D. The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease. Prz Gastroenterol 2024; 19(1): 1–8.
Copyright: © 2026 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
SUBMIT YOUR PAPER
Share
without publication fees
Coverage in
Integrated with
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications